It stands to reason that ASNS can compensate for amino acid deprivation by replacing the missing amino acid via biosynthesis, and indeed, the very leukemias that show a significant high GCN2 expression and low ASNS expression are also the same B-Cell derived leukemias in which asparaginase is an effective treatment. This evidence concerns the gene ASNS and leukemia.